Acute responses to opioidergic blockade as a biomarker of hedonic eating among obese women enrolled in a mindfulness-based weight loss intervention trial
- PMID: 25931433
- PMCID: PMC4485926
- DOI: 10.1016/j.appet.2015.04.062
Acute responses to opioidergic blockade as a biomarker of hedonic eating among obese women enrolled in a mindfulness-based weight loss intervention trial
Abstract
There are currently no commonly used or easily accessible 'biomarkers' of hedonic eating. Physiologic responses to acute opioidergic blockade, indexed by cortisol changes and nausea, may represent indirect functional measures of opioid-mediated hedonic eating drive and predict weight loss following a mindfulness-based intervention for stress eating. In the current study, we tested whether cortisol and nausea responses induced by oral ingestion of an opioidergic antagonist (naltrexone) correlated with weight and self-report measures of hedonic eating and predicted changes in these measures following a mindfulness-based weight loss intervention. Obese women (N = 88; age = 46.7 ± 13.2 years; BMI = 35.8 ± 3.8) elected to complete an optional sub-study prior to a 5.5-month weight loss intervention with or without mindfulness training. On two separate days, participants ingested naltrexone and placebo pills, collected saliva samples, and reported nausea levels. Supporting previous findings, naltrexone-induced cortisol increases were associated with greater hedonic eating (greater food addiction symptoms and reward-driven eating) and less mindful eating. Among participants with larger cortisol increases (+1 SD above mean), mindfulness participants (relative to control participants) reported greater reductions in food addiction symptoms, b = -0.95, SE(b) = 0.40, 95% CI [-1.74, -0.15], p = .021. Naltrexone-induced nausea was marginally associated with reward-based eating. Among participants who endorsed naltrexone-induced nausea (n = 38), mindfulness participants (relative to control participants) reported greater reductions in food addiction symptoms, b = -1.00, 95% CI [-1.85, -0.77], p = .024, and trended toward reduced reward-based eating, binge eating, and weight, post-intervention. Single assessments of naltrexone-induced cortisol increases and nausea responses may be useful time- and cost-effective biological markers to identify obese individuals with greater opioid-mediated hedonic eating drive who may benefit from weight loss interventions with adjuvant mindfulness training that targets hedonic eating.
Keywords: Cortisol; Hedonic eating; Mindfulness intervention; Naltrexone; Nausea.
Published by Elsevier Ltd.
Figures



Similar articles
-
Reduced reward-driven eating accounts for the impact of a mindfulness-based diet and exercise intervention on weight loss: Data from the SHINE randomized controlled trial.Appetite. 2016 May 1;100:86-93. doi: 10.1016/j.appet.2016.02.009. Epub 2016 Feb 8. Appetite. 2016. PMID: 26867697 Free PMC article. Clinical Trial.
-
A new biomarker of hedonic eating? A preliminary investigation of cortisol and nausea responses to acute opioid blockade.Appetite. 2014 Mar;74:92-100. doi: 10.1016/j.appet.2013.11.014. Epub 2013 Nov 27. Appetite. 2014. PMID: 24291355 Free PMC article.
-
Putting the brakes on the "drive to eat": Pilot effects of naltrexone and reward-based eating on food cravings among obese women.Eat Behav. 2015 Dec;19:53-6. doi: 10.1016/j.eatbeh.2015.06.008. Epub 2015 Jul 2. Eat Behav. 2015. PMID: 26164674 Free PMC article. Clinical Trial.
-
From taste hedonics to motivational drive: central μ-opioid receptors and binge-eating behaviour.Int J Neuropsychopharmacol. 2009 Aug;12(7):995-1008. doi: 10.1017/S146114570900039X. Epub 2009 May 12. Int J Neuropsychopharmacol. 2009. PMID: 19433009 Review.
-
Assessing the role of ghrelin and the enzyme ghrelin O-acyltransferase (GOAT) system in food reward, food motivation, and binge eating behavior.Pharmacol Res. 2021 Oct;172:105847. doi: 10.1016/j.phrs.2021.105847. Epub 2021 Aug 24. Pharmacol Res. 2021. PMID: 34438062 Review.
Cited by
-
Improving Assessment of the Spectrum of Reward-Related Eating: The RED-13.Front Psychol. 2017 May 30;8:795. doi: 10.3389/fpsyg.2017.00795. eCollection 2017. Front Psychol. 2017. PMID: 28611698 Free PMC article.
-
Reduced reward-driven eating accounts for the impact of a mindfulness-based diet and exercise intervention on weight loss: Data from the SHINE randomized controlled trial.Appetite. 2016 May 1;100:86-93. doi: 10.1016/j.appet.2016.02.009. Epub 2016 Feb 8. Appetite. 2016. PMID: 26867697 Free PMC article. Clinical Trial.
-
Obesity as a Condition Determined by Food Addiction: Should Brain Endocannabinoid System Alterations Be the Cause and Its Modulation the Solution?Pharmaceuticals (Basel). 2021 Sep 29;14(10):1002. doi: 10.3390/ph14101002. Pharmaceuticals (Basel). 2021. PMID: 34681224 Free PMC article. Review.
-
Stress as a potential moderator of ovarian hormone influences on binge eating in women.F1000Res. 2019 Feb 27;8:F1000 Faculty Rev-222. doi: 10.12688/f1000research.16895.1. eCollection 2019. F1000Res. 2019. PMID: 30854192 Free PMC article. Review.
-
Examining the mediating roles of binge eating and emotional eating in the relationships between stress and metabolic abnormalities.J Behav Med. 2016 Apr;39(2):320-32. doi: 10.1007/s10865-015-9699-1. Epub 2015 Dec 21. J Behav Med. 2016. PMID: 26686376 Free PMC article.
References
-
- Adam TC, Epel ES. Stress, eating and the reward system. Physiology & Behavior. 2007;91(4):449–458. - PubMed
-
- American Psychological Association . Diagnostic and statistical manual of mental disorders: DSM-IV-TR®. American Psychiatric Pub.; 2000.
Publication types
MeSH terms
Substances
Grants and funding
- K24AT007827/AT/NCCIH NIH HHS/United States
- 1U01HL097973/HL/NHLBI NIH HHS/United States
- P01 AT005013/AT/NCCIH NIH HHS/United States
- K24 AT007827/AT/NCCIH NIH HHS/United States
- P30 DK098722/DK/NIDDK NIH HHS/United States
- 1P01AT005013/AT/NCCIH NIH HHS/United States
- K01 AT004199/AT/NCCIH NIH HHS/United States
- K01AT004199/AT/NCCIH NIH HHS/United States
- U01 HL097973/HL/NHLBI NIH HHS/United States
- T32 AT003997/AT/NCCIH NIH HHS/United States
- UL1 TR000004/TR/NCATS NIH HHS/United States
- T32AT003997/AT/NCCIH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical